Dergiler / Psychiatry and behavioral sciences (Online) / 2020 / Cilt: 10 - Sayı: 3

Serotonin Syndrome in a Patient Using Paroxetine and Bupropion

Sayfa
155–157
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Serotonin syndrome is an important clinical condition that can occur after excessive central serotonergic activity, generally secondary to the use of combinations of antidepressants.
📊
Temel Bulgular & Veri:Selective serotonin reuptake inhibitors and bupropion are frequently used in the treatment of major depression in clinical practice.
💡
Sonuç & Katkı:The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Serotonin syndrome is an important clinical condition that can occur after excessive central serotonergic activity, generally secondary to the use of combinations of antidepressants. Selective serotonin reuptake inhibitors and bupropion are frequently used in the treatment of major depression in clinical practice. Few cases of serotonin syndrome due to the use of serotonergic antidepressants and bupropion have been reported in the literature. The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.

🔖

Bu Makaleye Atıf Yap

KIRKAŞ, A., UGUZ, F. (2020). Serotonin Syndrome in a Patient Using Paroxetine and Bupropion. Psychiatry and behavioral sciences (Online), Cilt: 10 - Sayı: 3, 155–157. https://ajindex.com/articles/302795

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (17)

  1. Volpi-Abadie J, Kaye AM, Kaye AD. Serotonin syndrome. Ochsner J 2013
  2. 40 [2] Ables AZ, Nagubilli R. Prevention, diagnosis, and management of serotonin syndrome. Am Fam Physician 2010
  3. Lane R, Baldwin D. Selective serotonin reuptake inhibitorinduced serotonin syndrome: review. J Clin Psychopharmacol 1997
  4. Dvir Y, Smallwood P. Serotonin syndrome: a complex but easily avoidable condition. Gen Hosp Psychiatry 2008
  5. Dhillon S, Yang LP, Curran MP. Bupropion: A review of its use in the management of major depressive disorder. Drugs 2008
  6. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Clinical Version (SCID-I/CV). Washington D.C: American Psychiatric Press
  7. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960
  8. Munhoz RP. Serotonin syndrome induced by a combination of bupropion and SSRIs. Clin Neuropharmacol 2004
  9. Thorpe EL, Pizon AF, Lynch MJ, Boyer J. Bupropion induced serotonin syndrome: a case report. J Med Toxicol 2010
  10. Falls BA, Gurrera RJ. Serotonin syndrome in a patient on tramadol, bupropion, trazodone, and oxycodone. Psychosomatics 2014
  11. Murray B, Carpenter J, Dunkley C, Moran TP, Kiernan EA, Rianprakaisang T, et al. Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity. J Med Toxicol 2020
  12. Sidlak AM, Koivisto KO, Marino RT, Abesamis MG. Serotonin toxicity from isolated bupropion overdoses. Clin Toxicol (Phila). 2020
  13. Moss MJ, Hendrickson RG, Toxicology Investigators Consortium (ToxIC). Serotonin Toxicity: Associated Agents and Clinical Characteristics. J Clin Psychopharmacol. 2019
  14. 39(6):628-633. [14] Sanchez C, Reines EH, Montgomery SA. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike? Int Clin Psychopharmacol 2014
  15. Costa R, Oliveira NG, Dinis-Oliveira RJ. Pharmacokinetic and pharmacodynamic of bupropion: integrative overview of relevant clinical and forensic aspects. Drug Metab Rev. 2019
  16. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned- Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004
  17. El Mansari M, Ghanbari R, Janssen S, Blier P. Sustained administration of bupropion alters the neur